<DOC>
	<DOCNO>NCT01121315</DOCNO>
	<brief_summary>To describe type II diabetes population primary care special reference treatment , diseases mortality last decade . To test hypothesis type combination per oral glucose lower drug different effect risk cardiovascular disease diabetic complication .</brief_summary>
	<brief_title>A Retrospective Study Cardiovascular Events Related Use Glucose Lowering Drug Treatment Primary Care</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Patients type II diabetes , accord medical record , diagnosis , prescription lab assessment Patients follow physician less 6 month diagnosis Diabetes type II</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Epidemiological</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Glucose Lowering Drug Treatment Primary care</keyword>
	<keyword>CVD</keyword>
</DOC>